Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Anticancer Research|March 29, 2022
Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR MutationsChi-Han Chen, John Wen-Cheng Chang, Ching-Fu Chang, et al.Thoracic Cancer|January 27, 2024
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancerLi-Chung Chiu, Ping-Chih Hsu, Chin-Chou Wang, et al.Cancers|October 27, 2022
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer PatientsYan-Jei Tang, John Wen-Cheng Chang, Ching-Fu Chang, et al.Thoracic Cancer|August 1, 2023
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinibChen-Te Wu, Ping-Chih Hsu, John Wen-Cheng Chang, et al.Oncotarget|December 3, 2016
YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cellsYuyuan Dai, Shu Liu, Wen-Qian Zhang, et al.Journal of Cellular and Molecular Medicine|March 26, 2018
Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesotheliomaPing-Chih Hsu, Jinbai Miao, Yu-Cheng Wang, et al.Cancer Medicine|February 27, 2026
Dacomitinib as a First-Line Therapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational StudyPing-Chih Hsu, How-Wen Ko, Li-Chung Chiu, et al.Oncotarget|July 14, 2016
YAP promotes erlotinib resistance in human non-small cell lung cancer cellsPing-Chih Hsu, Bin You, Yi-Lin Yang, et al.Thoracic Cancer|April 17, 2025
Baseline and changes in inflammatory parameters for patients with EGFR-mutated NSCLC treated with afatinibZi-Ting Chang, Ping-Chih Hsu, How-Wen Ko, et al.Oncology Letters|March 12, 2025
Clinical outcome analysis of different first‑ and second‑generation EGFR‑tyrosine kinase inhibitors in untreated patients with EGFR‑mutated non‑small cell lung cancer with baseline brain metastasisChen-Chuan Hsu, Li-Chung Chiu, How-Wen Ko, et al.Pageof 8